Safety and clinical activity of durvalumab combined with tremelimumab in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase I study
-
Published:2024-08
Issue:8
Volume:9
Page:103646
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Algazi A.ORCID,
Papadopoulos K.P.ORCID,
Tsai F.,
Hansen A.R.,
Angra N.,
Das M.,
Sheth S.ORCID,
Siu L.L.ORCID